DK1083929T3 - Anvendelse af anabolske stoffer - Google Patents

Anvendelse af anabolske stoffer

Info

Publication number
DK1083929T3
DK1083929T3 DK99927137T DK99927137T DK1083929T3 DK 1083929 T3 DK1083929 T3 DK 1083929T3 DK 99927137 T DK99927137 T DK 99927137T DK 99927137 T DK99927137 T DK 99927137T DK 1083929 T3 DK1083929 T3 DK 1083929T3
Authority
DK
Denmark
Prior art keywords
composition
anabolic drugs
anabolic
drugs
aminosugar
Prior art date
Application number
DK99927137T
Other languages
English (en)
Inventor
Todd R Henderson
Tarek Hammad
Medhat Soliman
Barbara Corson
Louis Lipiello
Robert Henderson
Original Assignee
Nutramax Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27375912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1083929(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/249,335 external-priority patent/US6451771B1/en
Application filed by Nutramax Lab Inc filed Critical Nutramax Lab Inc
Application granted granted Critical
Publication of DK1083929T3 publication Critical patent/DK1083929T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DK99927137T 1998-06-05 1999-06-03 Anvendelse af anabolske stoffer DK1083929T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8820598P 1998-06-05 1998-06-05
US09/249,335 US6451771B1 (en) 1999-02-12 1999-02-12 Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US27488199A 1999-03-23 1999-03-23
PCT/US1999/012152 WO1999062459A2 (en) 1998-06-05 1999-06-03 Agents and methods for protection, treatment and repair of connective tissue

Publications (1)

Publication Number Publication Date
DK1083929T3 true DK1083929T3 (da) 2007-06-11

Family

ID=27375912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99927137T DK1083929T3 (da) 1998-06-05 1999-06-03 Anvendelse af anabolske stoffer

Country Status (12)

Country Link
US (2) US8846118B2 (da)
EP (2) EP1083929B1 (da)
JP (1) JP4739522B2 (da)
AT (1) ATE353671T1 (da)
AU (2) AU770010B2 (da)
CA (1) CA2333755C (da)
CY (1) CY1107598T1 (da)
DE (1) DE69935140T2 (da)
DK (1) DK1083929T3 (da)
ES (1) ES2278447T3 (da)
PT (1) PT1083929E (da)
WO (1) WO1999062459A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492349B1 (en) * 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US8278291B1 (en) 1999-08-13 2012-10-02 Curadis Gmbh Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
FR2813195B1 (fr) 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
JPWO2002055074A1 (ja) 2001-01-05 2004-05-13 協和醗酵工業株式会社 関節炎の予防剤または治療剤
WO2002098449A1 (fr) * 2001-06-01 2002-12-12 Nippon Meat Packers, Inc. Medications pour lesions des articulations et aliments fonctionnels
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
EP2156842A4 (en) * 2007-06-01 2013-01-23 Kyowa Hakko Bio Co Ltd ORAL COMPOSITION
WO2010146078A2 (en) * 2009-06-16 2010-12-23 Bergen Teknologioverføring As Novel uses of hydroxyproline compositions
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US9421234B2 (en) * 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
WO2013110077A1 (en) * 2012-01-19 2013-07-25 Hybrid Medical, Llc Topical therapeutic formulations
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9231977B2 (en) * 2013-12-23 2016-01-05 Nokia Technologies Oy Method and apparatus for providing collaborative privacy policies for a shared device
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB856493A (en) * 1957-10-04 1960-12-21 Pfizer & Co C Therapeutic compositions comprising tetracycline antibiotics
FR2193M (fr) * 1962-09-10 1963-12-09 Lipha Nouveau médicament pour le traitement des maladies infectieuses.
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
EP0662838A4 (en) * 1992-09-25 1996-07-24 Autoimmune Inc PROCESS FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS WITH TYPE II COLLAGEN.
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
US5827874A (en) 1995-05-05 1998-10-27 Meyer; Hans Methods of treating pain and inflammation with proline
US6255295B1 (en) * 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
FR2770777B1 (fr) * 1997-11-10 2000-02-25 Fabre Pierre Dermo Cosmetique Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals

Also Published As

Publication number Publication date
AU770010B2 (en) 2004-02-12
ES2278447T3 (es) 2007-08-01
EP1083929B1 (en) 2007-02-14
US8753697B2 (en) 2014-06-17
US20090087503A1 (en) 2009-04-02
EP1083929A2 (en) 2001-03-21
CY1107598T1 (el) 2013-03-13
PT1083929E (pt) 2007-05-31
EP2272535A1 (en) 2011-01-12
CA2333755C (en) 2012-11-27
WO1999062459A3 (en) 2000-02-24
WO1999062459A2 (en) 1999-12-09
DE69935140T2 (de) 2007-05-31
DE69935140D1 (de) 2007-03-29
WO1999062459A9 (en) 2000-04-27
EP1083929A4 (en) 2002-11-27
US8846118B2 (en) 2014-09-30
AU2009202256B2 (en) 2011-09-22
AU2009202256A1 (en) 2009-07-02
JP4739522B2 (ja) 2011-08-03
AU4411599A (en) 1999-12-20
JP2002516829A (ja) 2002-06-11
US20100105632A1 (en) 2010-04-29
CA2333755A1 (en) 1999-12-09
ATE353671T1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
CY1107598T1 (el) Η χρηση αναβολικων παραγοντων, αντι-καταβολικων παραγοντων, αντιοξειδωτικων παραγοντων, και αναλγητικων για προστασια, θepαπεια και επιδιορθωση συνδετικου ιστου σε ανθρωπους και ζωα
FI954654A0 (fi) Aminosokeri- ja glykosaminoglykaanikoostumus sidekudosvauroiden hoitoon ja korjaukseen
BR9713866A (pt) Composição farmacéutica
BR9509858A (pt) Sistema de restauração de ligamento e tend o
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
CL2010000828A1 (es) Composicion farmaceutica que comprende un conjugado pegilado de interferon alfa y ribavirina, util en la preparacion de un medicamento para las infecciones de hepatitis c cronica.
WO1998022034A3 (en) Interventional photonic energy emitter system
AU5622198A (en) Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
PT952829E (pt) Composicao farmaceutica de fenofibrato que apresenta uma biodisponibilidade elevada e seu modo de preparacao
GB0123381D0 (en) Factor
DE69932510D1 (de) Vaskularisierungsinhibitoren
PT998287E (pt) Utilizacao de levobupivacaina
BR9809571A (pt) Composição medicinal e processo para produzì-la
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
GB2317109B (en) A therapeutic composition for the treatment and repair of connective tissue in mammals
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
BR0107544A (pt) Composição de promoção de secreção de bile
MXPA01011924A (es) Metodos y composiciones para modular la respuesta inmunitaria y para el tratamiento de trastornos inflamatorios.
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
NO874241D0 (no) Terapeutisk aktive salter.
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
PT834316E (pt) Utilizacao da sulbutiamina para a obtencao de composicoes farmaceuticas uteis no tratamento de certas perturbacoes psicomotoras e psico-intelectuais